1 / 2

Biosimilar Market Analysis, Share By 2029 | StraitsResearch

The global biosimilar market was valued at USD 4.49 billion in 2017 and is anticipated to reach USD 22.43 billion by 2023 at a CAGR of 30.9%. <br>https://straitsresearch.com/report/biosimilar-market/<br><br>

kiran110695
Download Presentation

Biosimilar Market Analysis, Share By 2029 | StraitsResearch

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosimilar Market Demand, Future Growth, Share By 2029 | StraitsResearch The latest research report, titled “Biosimilar Market” Added byStraits Research, provides the reader with a comprehensive overview of the Biosimilar Market Industry and familiarizes them with the latest market trends, industry information, and market share. The report content includes industry drivers, latest technology advancement, geographic trends, global market statistics, market forecasts, producers, and raw material suppliers. The global biosimilar market was valued at USD 4.49 billion in 2017 and is anticipated to reach USD 22.43 billion by 2023 at a CAGR of 30.9%. Impact of COVID-19 On Biosimilar Market: Last but not the least, we all are aware of the ongoing covid-19 pandemic and it still conveys on impacting the development of numerous markets across the globe. However, the direct effect of the pandemic differs based on market demand. Though some markets might observe a decrease in demand, several others will carry on to stay unharmed and present potential expansion opportunities. Interested to Procure the Data? Request Sample Here @ https://straitsresearch.com/report/biosimilar-market/request-sample

  2. Detailed Segmentation of Global Biosimilar Market : By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Recombinant Peptides By Disease: Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Diseases Market Regional Overview of Global Biosimilar Geographically, the Biosimilar market report studies the top producers, importer/exporter, and consumers, focuses on product capacity, production, value, consumption, market share, and growth opportunity in these key regions, covering: North America, Europe, Asia Pacific, Central & South America, Middle East & Africa and Others. Biosimilar Market Competition by Top Manufacturers as Follow: Various leaders along with players that are emerging have been profiled in this report such as The market is integrated with the presence of Biocon, Pfizer, Inc., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH (A Novartis Division), Celltrion Inc., Teva Pharmaceutical Industries Ltd., STADA Arzneimittel AG, Amgen, Inc., and Apotex Inc. (Apobiologix) that are a major part of the industry. Click Here Request for Customization of This Research Report @ https://straitsresearch.com/report/biosimilar-market About Us: StraitsResearch.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Contact Us: Email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 6464807505, +44 203 318 2846 Website: https://straitsresearch.com/

More Related